WO2003073985A3 - New methods of using antiangiogenic agents - Google Patents

New methods of using antiangiogenic agents Download PDF

Info

Publication number
WO2003073985A3
WO2003073985A3 PCT/US2003/005898 US0305898W WO03073985A3 WO 2003073985 A3 WO2003073985 A3 WO 2003073985A3 US 0305898 W US0305898 W US 0305898W WO 03073985 A3 WO03073985 A3 WO 03073985A3
Authority
WO
WIPO (PCT)
Prior art keywords
new methods
antiangiogenic agents
methods
angiogensis
methoxyestradiol
Prior art date
Application number
PCT/US2003/005898
Other languages
French (fr)
Other versions
WO2003073985A2 (en
Inventor
Theresa M Lavallee
Victor S Pribluda
Jonathan Simons
Nicola Mabjeesh
Paraskevi Giannakakou
Original Assignee
Entremed Inc
Theresa M Lavallee
Victor S Pribluda
Jonathan Simons
Nicola Mabjeesh
Paraskevi Giannakakou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entremed Inc, Theresa M Lavallee, Victor S Pribluda, Jonathan Simons, Nicola Mabjeesh, Paraskevi Giannakakou filed Critical Entremed Inc
Priority to AU2003217754A priority Critical patent/AU2003217754A1/en
Publication of WO2003073985A2 publication Critical patent/WO2003073985A2/en
Publication of WO2003073985A3 publication Critical patent/WO2003073985A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compositions and methods for treating mammalian disease characterized by undesirable angiogenesis and for controlling a number of angiogensis-related events, conditions, or substances, by administering derivatives of 2-methoxyestradiol of general formula (I) wherein the variables are defined in the specification.
PCT/US2003/005898 2002-03-01 2003-02-27 New methods of using antiangiogenic agents WO2003073985A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003217754A AU2003217754A1 (en) 2002-03-01 2003-02-27 New methods of using antiangiogenic agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36126702P 2002-03-01 2002-03-01
US60/361,267 2002-03-01

Publications (2)

Publication Number Publication Date
WO2003073985A2 WO2003073985A2 (en) 2003-09-12
WO2003073985A3 true WO2003073985A3 (en) 2003-12-31

Family

ID=27789102

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/005898 WO2003073985A2 (en) 2002-03-01 2003-02-27 New methods of using antiangiogenic agents

Country Status (2)

Country Link
AU (1) AU2003217754A1 (en)
WO (1) WO2003073985A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7875282B2 (en) * 2004-03-22 2011-01-25 Cordis Corporation Coated medical device for local vascular delivery of Panzem® in combination with rapamycin to prevent restenosis following vascular injury
US7718624B2 (en) * 2004-09-01 2010-05-18 Sitkovsky Michail V Modulation of immune response and inflammation by targeting hypoxia inducible factors
WO2017205964A1 (en) * 2016-06-02 2017-12-07 UNIVERSITé LAVAL Aminosteroid derivatives and process for producing same
CN107746420B (en) * 2017-09-28 2020-08-14 湖南新合新生物医药有限公司 Preparation method of 16 beta alkyl steroid compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504074A (en) * 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US5643900A (en) * 1993-07-02 1997-07-01 Fotsis; Theodore Method for treatment of pathological conditions associated with angiogenesis and preparation therefor
US5958892A (en) * 1996-07-30 1999-09-28 Board Of Regents, The University Of Texas System 2-methoxyestradiol-induced apoptosis in cancer cells

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643900A (en) * 1993-07-02 1997-07-01 Fotsis; Theodore Method for treatment of pathological conditions associated with angiogenesis and preparation therefor
US5504074A (en) * 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US5958892A (en) * 1996-07-30 1999-09-28 Board Of Regents, The University Of Texas System 2-methoxyestradiol-induced apoptosis in cancer cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BOGDANOVIC S. ET AL.: "2-Methoxyestradiol: an orally active endogenous inhibitor of angiogenesis", ENTREMED-THE ANGIOGENESIS COMPANY. ANGIOGENESIS PLAYERS, FINANCIAL TIMES PHARMACEUTICALS, 1999, 7 November 2000 (2000-11-07), pages 1 - 10, XP002968945 *

Also Published As

Publication number Publication date
AU2003217754A1 (en) 2003-09-16
AU2003217754A8 (en) 2003-09-16
WO2003073985A2 (en) 2003-09-12

Similar Documents

Publication Publication Date Title
WO2005030120A3 (en) Antiangiogenic agents
WO2003063791A3 (en) Non-steroidal analogs of 2-methoxyestradiol
WO2005005453A3 (en) Novel compounds and compositions comprising sterols and/or stanols and cholesterol biosynthesis inhibitors and use thereof in treating or preventing a variety of diseases and conditions.
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
WO2005077968A3 (en) 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
NO20011721D0 (en) N-aralkylaminotetralins as ligands for neuropeptide Y Y5 receptor
WO2005116002A3 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO1999002497A3 (en) Pyridine derivatives
WO2002042319A3 (en) 2-substituted estrogens as antiangiogenic agents
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
GEP20094638B (en) Benzimidazolone carboxylic acid derivatives
BR0309278A (en) Compound, composition, methods for modulating ksp kinesin activity, for inhibiting ksp, for the treatment of a cell proliferative disease, and use of a compound
WO2000023407A3 (en) Ureido-thiobutyric acid derivatives as ppar-agonists
WO2000071515A3 (en) INHIBITORS OF FACTOR Xa
WO2004043456A8 (en) Cholesterol absorption inhibitors for the treatment of demyelination
AU5343698A (en) New benzofuranone derivatives and a method for producing them
DE60015508T2 (en) C-16 UNAUDITED FP-SELECTIVE PROSTAGLANDIN ANALOGUE
WO1995018821A3 (en) Novel antiandrogenic agents and related pharmaceutical compositions and methods of use
WO2004032840A3 (en) Compounds, compositions, and methods
WO2003073985A3 (en) New methods of using antiangiogenic agents
AU2003213661A1 (en) Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
WO2002006280A3 (en) INHIBITORS OF FACTOR Xa
WO2003053352A3 (en) Therapeutic compounds for treating dyslipidemic conditions
WO2004052350A3 (en) Method of treating movement disorders using barbituric acid derivatives
WO2004032879A3 (en) Compounds, compositions, and methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP